Instituto De Investigación Biomédica De Salamanca

This study tests whether giving a higher total dose of radiation, split into two treatments each day, can help people with limited-stage small cell lung cancer live longer without the cancer growing. All 300 participants will receive standard chemotherapy, and they will be random…

This study tests a new treatment called TranspoCART19 for people with B-cell lymphoma that has come back or not responded to standard therapy. The treatment uses a patient's own immune cells, which are modified in a lab to better recognize and attack cancer cells. The main goals …

This study tests a new computer program that helps doctors diagnose blocked heart arteries from CT scans more accurately. Researchers will look at past scans from 1,000 patients to see if the software can reduce the need for invasive tests like angiograms. The goal is to make dia…

This study tests whether a tailored exercise program, designed by a primary care team, can improve physical fitness and quality of life in adults aged 65 and older living in rural areas. Participants will receive a custom plan including aerobic, strength, and balance exercises, a…

This study tests whether a much smaller dose of a dye (indocyanine green) given just before surgery works as well as the standard larger dose given hours earlier. The dye helps surgeons see the bile ducts clearly during gallbladder removal, which may reduce the risk of accidental…

This study follows 400 adults with long COVID for four years to see how their symptoms, especially fatigue, change over time. Researchers will use blood tests and artery stiffness measurements to find biological markers that predict recovery or worsening. The goal is to help doct…

This study aims to find biological markers in the blood and tumor that can predict which patients with a common skin cancer will respond to the immunotherapy drug cemiplimab, and who might experience side effects. Researchers will use advanced cell analysis techniques to study im…